Insufficient scRNA-seq data for expression of CLC at single-cell level.
Insufficient scRNA-seq data for expression of CLC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 71% | 71.93 | 413 / 578 | 30% | 2.81 | 346 / 1155 |
spleen | 96% | 221.98 | 232 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 2298.26 | 886 / 929 | 0% | 0 | 0 / 0 |
intestine | 35% | 21.49 | 339 / 966 | 46% | 6.44 | 240 / 527 |
stomach | 10% | 4.69 | 37 / 359 | 51% | 6.25 | 145 / 286 |
bladder | 5% | 1.14 | 1 / 21 | 34% | 4.64 | 170 / 504 |
liver | 27% | 8.07 | 62 / 226 | 2% | 0.21 | 9 / 406 |
pancreas | 5% | 3.15 | 15 / 328 | 24% | 1.45 | 42 / 178 |
adipose | 20% | 7.56 | 236 / 1204 | 0% | 0 | 0 / 0 |
kidney | 11% | 2.02 | 10 / 89 | 8% | 0.30 | 75 / 901 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.82 | 5 / 29 |
adrenal gland | 6% | 1.25 | 15 / 258 | 11% | 0.36 | 26 / 230 |
esophagus | 4% | 1.58 | 54 / 1445 | 13% | 0.46 | 24 / 183 |
ovary | 1% | 0.14 | 1 / 180 | 12% | 0.39 | 52 / 430 |
heart | 12% | 3.42 | 104 / 861 | 0% | 0 | 0 / 0 |
thymus | 10% | 2.91 | 66 / 653 | 2% | 0.03 | 10 / 605 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.34 | 5 / 45 |
uterus | 2% | 0.37 | 3 / 170 | 8% | 0.33 | 36 / 459 |
breast | 7% | 2.35 | 31 / 459 | 3% | 0.18 | 31 / 1118 |
brain | 6% | 2.31 | 157 / 2642 | 2% | 0.11 | 13 / 705 |
blood vessel | 6% | 2.52 | 86 / 1335 | 0% | 0 | 0 / 0 |
prostate | 2% | 0.31 | 5 / 245 | 3% | 0.06 | 17 / 502 |
muscle | 2% | 0.66 | 16 / 803 | 0% | 0 | 0 / 0 |
skin | 0% | 0.10 | 9 / 1809 | 1% | 0.05 | 7 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002667 | Biological process | regulation of T cell anergy |
GO_0046006 | Biological process | regulation of activated T cell proliferation |
GO_0070231 | Biological process | T cell apoptotic process |
GO_0002724 | Biological process | regulation of T cell cytokine production |
GO_0005829 | Cellular component | cytosol |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0097153 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic process |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CLC |
Protein name | Galectin-10 (Gal-10) (Charcot-Leyden crystal protein) (CLC) (Eosinophil lysophospholipase) (Lysolecithin acylhydrolase) |
Synonyms | LGALS10A LGALS10 |
Description | FUNCTION: Regulates immune responses through the recognition of cell-surface glycans. Essential for the anergy and suppressive function of CD25-positive regulatory T-cells (Treg). . |
Accessions | ENST00000221804.5 Q05315 |